BNIGF News and Press, Beroni Group Ltd From 08/12/20

BNIGF - Beroni Group Signs Agreement with Genscript Biotech Corporation to Conduct Further Study to Develop Nanobody-based Medical Solution for COVID-19

NEW YORK and SYDNEY, Australia, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), is pleased to announce that further to its announcement on August 4, 2020 regarding the development of a medical solution utilizin...

BNIGF - Beroni Group Has Successfully Constructed and Purified 24 Types of Nanobodies for Detection and Treatment of COVID-19

NEW YORK and SYDNEY, Australia, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization o...

BNIGF - Beroni Group Limited (BNIGF) Constructed Nanobodies for Coronavirus

Sydney, Australia (ABN Newswire) - Beroni Group (OTCMKTS:BNIGF) (NSX:BTG), an international diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases, today announced its further p...

BNIGF - Beroni Group Limited (BNIGF) Beroni to Supply COVID-19 Antibody Test Kit to Japan

Sydney, Australia (ABN Newswire) - Beroni Group (OTCMKTS:BNIGF) (NSX:BTG), an international diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases, is pleased to announce that i...

BNIGF - Beroni teams up with Japanese partners for COVID-19 antibody test kit supply

Beroni Group ( OTCQX:BNIGF ) partners with Forsitech and Standard Capital to supply its SARS-CoV-2 total antibody detection kit for clinical testing in the Japanese market. More news on: Beroni Group Limited, Healthcare stocks news, Read more ...

BNIGF - Beroni Group to Supply COVID-19 Antibody Test Kit to Japan

NEW YORK and SYDNEY, Australia, July 10, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization o...

BNIGF - Dr Richard Buchta Appointed as Director of Beroni Group

NEW YORK and SYDNEY, Australia, June 30, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization o...

BNIGF - Beroni Group Limited (BNIGF) Issue of shares

Sydney, Australia (ABN Newswire) - Beroni Group (OTCMKTS:BNIGF) (NSX:BTG), an international diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases, is pleased to announce that, ...

BNIGF - Beroni Group Limited (BNIGF) Issue of US$2.97m Convertible Notes to Fund Growth

Sydney, Australia (ABN Newswire) - Beroni Group (OTCMKTS:BNIGF) (NSX:BTG), an international diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases, is pleased to announce that i...

BNIGF - Beroni Group Issues US$2.97 million of Convertible Notes to Fund Growth Plans

NEW YORK and SYDNEY, Australia, May 27, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of...

Company Name:	Beroni Group Ltd
Stock Symbol:	BNIGF
Market:	OTC
Website:	beronigroup.com